Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-091366
Filing Date
2011-04-07
Accepted
2011-04-07 17:08:13
Documents
3
Period of Report
2011-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11372
2 FEBRUARY 25, 2011 NOTICE OF MEETING AND RECORD DATE dex991.htm EX-99.1 3046
3 GRAPHIC g172063g31a53.jpg GRAPHIC 63235
  Complete submission text file 0001193125-11-091366.txt   102704
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 11746789
SIC: 2834 Pharmaceutical Preparations